[Does obesity modify recurrence-free interval in breast cancer?].
Kurz
C
C
I. Univers.-Frauenklinik Wien.
Obermair
A
A
Schemper
W
W
Kubista
E
E
Sevelda
P
P
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D018270:Carcinoma, Ductal, Breast / Q000401:mortality / Q000473:pathology / Q000628:therapy; D018275:Carcinoma, Lobular / Q000401:mortality / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000628:therapy; D009367:Neoplasm Staging; D009376:Neoplasms, Hormone-Dependent / Q000401:mortality / Q000473:pathology / Q000628:therapy; D009765:Obesity / Q000150:complications / Q000401:mortality* / Q000473:pathology; D011446:Prospective Studies; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012307:Risk Factors; D015996:Survival Rate
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
Beeinflusst Adipositas das rezidivfreie Intervall beim Mammakarzinom?